Publisher
Springer Berlin Heidelberg
Reference10 articles.
1. Böhmer G, Petry KU, Iftner T, Brummer O, Günter HH, Flemming P, Kühnle H (2002) Der DNS-Nachweis humaner Papillomaviren mittels Hybrid Capture ist als sekundäre Screeningmethode bei rezidivierenden atypischen Abstrichen der Befundklasse Pap III D ungeeignet. Zentralbl Gynakol 124:111–115
2. Condel JL, Mahood LK, Grzybicki DM, Sturgis CD, Raab SS (2002) Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist. Am J Clin Pathol 117: 534–540
3. Hughes SA, Sun D, Gibson C, Bellerose B, Rushing L, Chen H, Harlow BL, Genest DR, Sheets EE, Crum CP (2002) Managing atypical squamous cells of undetermined significance (ASCUS): human papillomavirus testing, ASCUS subtyping, or follow-up cytology? Am J Obstet Gynecol 186: 396–403
4. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A (2000) Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. CMAJ 163: 701–707
5. Miller AB (2002) Der natürliche Verlauf einer Infektion der Cervix uteri mit humanen Papillomaviren. FRAUENARZT 43: 686–690